06.30.2020

Roche wards off Herceptin copycats with new, easy-to-use Perjeta combo product

Roche wards off Herceptin copycats with new, easy-to-use Perjeta combo product chelfand Tue, 06/30/2020 - 11:49
06.30.2020

With more nays than yeas for Gilead's remdesivir pricing, are pharma's rep gains sunk?

With more nays than yeas for Gilead's remdesivir pricing, are pharma's rep gains sunk? beth.bulik Tue, 06/30/2020 - 10:03
06.30.2020

GSK's Duvroq, Akebia's Vafseo win global first nods in Japan to challenge Astellas' anemia drug

GSK's Duvroq, Akebia's Vafseo win global first nods in Japan to challenge Astellas' anemia drug aliu Tue, 06/30/2020 - 09:45
06.30.2020

FDA will require 50% efficacy for COVID-19 vaccines. How high is that bar?

FDA will require 50% efficacy for COVID-19 vaccines. How high is that bar? esagonowsky Tue, 06/30/2020 - 09:20
06.30.2020

Merck's Keytruda lands new colorectal cancer nod, its 2nd biomarker-based OK this month

Merck's Keytruda lands new colorectal cancer nod, its 2nd biomarker-based OK this month chelfand Tue, 06/30/2020 - 04:00
06.30.2020

Novavax hires new manufacturing chief to take COVID-19, flu vaccine hopefuls across the finish line

Novavax hires new manufacturing chief to take COVID-19, flu vaccine hopefuls across the finish line kblankenship Mon, 06/29/2020 - 23:03
06.29.2020

Alnylam's RNAi therapy Givlaari shows lasting effect one year into treatment, new data show

Alnylam's RNAi therapy Givlaari shows lasting effect one year into treatment, new data show kblankenship Mon, 06/29/2020 - 18:15
06.29.2020

With calls for American-made drugs on the rise, a Michigan CDMO is scaling up to meet demand

With calls for American-made drugs on the rise, a Michigan CDMO is scaling up to meet demand kblankenship Mon, 06/29/2020 - 15:57
06.29.2020

Intercept's NASH hopeful spurned by FDA, raising questions for other companies in the race

Intercept's NASH hopeful spurned by FDA, raising questions for other companies in the race esagonowsky Mon, 06/29/2020 - 11:29
06.29.2020

Pfizer sues to cut Vyndaqel copays, calling Medicare ban unconstitutional

Pfizer sues to cut Vyndaqel copays, calling Medicare ban unconstitutional aliu Mon, 06/29/2020 - 11:12